Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models. [electronic resource]
Producer: 20161101Description: e1137415 p. digitalISSN:- 1938-2022
- Animals
- Diabetes Mellitus, Experimental
- Diabetes Mellitus, Type 2 -- diagnosis
- Disease Progression
- Exenatide
- Glucagon-Like Peptide 1
- Hypoglycemic Agents -- therapeutic use
- Insulin-Secreting Cells -- drug effects
- Islets of Langerhans -- drug effects
- Mice
- Mice, Obese
- Peptides -- therapeutic use
- Receptors, Glucagon -- antagonists & inhibitors
- Venoms -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.